News from joint project manager transformational medical technologies A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 02, 2012, 16:41 ET
JPM-TMT, a component of the Joint Program Executive Office for Chemical and Biological Defense, aims to protect the Warfighter from emerging infectious diseases, genetically altered and unknown biological threats. Through strategic investments and partnerships with innovative biotech firms, pharmaceutical corporations, other government agencies, and academic institutions, JPM-TMT facilitates the advanced development and acquisition of broad-spectrum medical countermeasures and systems to enhance our nation's biodefense response capability. For more information, visit www.jpmtmt.mil.  (PRNewsFoto/Joint Project Manager Transformational Medical Technologies)

JPM-TMT Announces Down Selection Decision for Ebola Drug Candidates

JPM-TMT's Strategy in Accordance with Original RFP  The Department of Defense's (DoD) Joint Program Executive Office for Chemical...

Sep 06, 2012, 09:58 ET
JPM-TMT, a component of the Joint Program Executive Office for Chemical and Biological Defense, aims to protect the Warfighter from emerging infectious diseases, genetically altered and unknown biological threats. Through strategic investments and partnerships with innovative biotech firms, pharmaceutical corporations, other government agencies, and academic institutions, JPM-TMT facilitates the advanced development and acquisition of broad-spectrum medical countermeasures and systems to enhance our nation's biodefense response capability. For more information, visit www.jpmtmt.mil.  (PRNewsFoto/Joint Project Manager Transformational Medical Technologies)

JPM-TMT Awards New Contract to Study Administration using Marburg Virus Drug

Sarepta Therapeutics, Inc. Will Investigate feasibility of Delivery via Intramuscular Route  A contract to evaluate an alternative...

Aug 02, 2012, 11:17 ET
JPM-TMT, a component of the Joint Program Executive Office for Chemical and Biological Defense, aims to protect the Warfighter from emerging infectious diseases, genetically altered and unknown biological threats. Through strategic investments and partnerships with innovative biotech firms, pharmaceutical corporations, other government agencies, and academic institutions, JPM-TMT facilitates the advanced development and acquisition of broad-spectrum medical countermeasures and systems to enhance our nation's biodefense response capability. For more information, visit www.jpmtmt.mil.  (PRNewsFoto/Joint Project Manager Transformational Medical Technologies)

Test Results Show Unprecedented Achievement for Marburg Drug Candidate

Treatment with JPM-TMTFunded AVI-7288 Shows Significant Survival Rates Even When Administered up to Four Days Post Infection   A...

Mar 15, 2012, 14:23 ET
JPM-TMT, a component of the Joint Program Executive Office for Chemical and Biological Defense, aims to protect the Warfighter from emerging infectious diseases, genetically altered and unknown biological threats. Through strategic investments and partnerships with innovative biotech firms, pharmaceutical corporations, other government agencies, and academic institutions, JPM-TMT facilitates the advanced development and acquisition of broad-spectrum medical countermeasures and systems to enhance our nation's biodefense response capability. For more information, visit www.jpmtmt.mil.  (PRNewsFoto/Joint Project Manager Transformational Medical Technologies)

JPM-TMT Announces Contract Award for Advanced Development of Broad-spectrum Influenza Drug

MediVector, Inc.'s Favipiravir (T-705) targets multiple influenza virus strains The Department of Defense's (DOD) Joint Project Manager...